Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: OutcomeDefinition for End-stage kidney disease

Raw xml | Download


<EvidenceVariable xmlns="http://hl7.org/fhir">
  <id value="236965"/>
  <meta>
    <versionId value="71"/>
    <lastUpdated value="2026-08-06T19:22:47.560Z"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 236965</b></p><a name="236965"> </a><a name="hc236965"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 71; Last updated: 2026-08-06 19:22:47+0000</p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/236965">https://fevir.net/resources/EvidenceVariable/236965</a></p><p><b>identifier</b>: FEvIR Object Identifier/236965, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313960, outcomeId/313960, picoId/85798, sectionId/73215</p><p><b>name</b>: End_stage_kidney_disease313960</p><p><b>title</b>: OutcomeDefinition for End-stage kidney disease</p><p><b>shortTitle</b>: End-stage kidney disease</p><p><b>citeAs</b>: </p><div><p>OutcomeDefinition for End-stage kidney disease [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236965. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236965. Computable resource at: https://fevir.net/resources/EvidenceVariable/236965#json.</p>
</div><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>End-stage kidney disease</p>
</div><p><b>copyright</b>: </p><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>
</div><h3>RelatesTos</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-relationship-type part-of}">Part Of</span></td><td>MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</td></tr></table><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:">End-stage kidney disease</span></td></tr></table><p><b>handling</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000090}">dichotomous variable</span></p></div>
  </text>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <url value="https://fevir.net/resources/EvidenceVariable/236965"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="236965"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <type>
      <text value="FEvIR Linking Identifier"/>
    </type>
    <system value="https://fevir.net/FLI"/>
    <value value="MAGIC-5288-j1Wqrn-313960"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <type>
      <text value="outcomeId"/>
    </type>
    <system value="https://app.magicapp.org/#/guidelines"/>
    <value value="313960"/>
  </identifier>
  <identifier>
    <type>
      <text value="picoId"/>
    </type>
    <system value="https://app.magicapp.org/#/guidelines"/>
    <value value="85798"/>
  </identifier>
  <identifier>
    <type>
      <text value="sectionId"/>
    </type>
    <system value="https://app.magicapp.org/#/guidelines"/>
    <value value="73215"/>
  </identifier>
  <name value="End_stage_kidney_disease313960"/>
  <title value="OutcomeDefinition for End-stage kidney disease"/>
  <shortTitle value="End-stage kidney disease"/>
  <citeAs
          value="OutcomeDefinition for End-stage kidney disease [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236965. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236965. Computable resource at: https://fevir.net/resources/EvidenceVariable/236965#json."/>
  <status value="active"/>
  <author>
    <name value="Computable Publishing®: MAGIC-to-FEvIR Converter"/>
  </author>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description value="End-stage kidney disease"/>
  <copyright
             value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/>
  <relatesTo>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/artifact-relationship-type"/>
        <code value="part-of"/>
        <display value="Part Of"/>
      </coding>
    </type>
    <targetReference>
      <type value="Composition"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="MAGIC-5288-j1Wqrn-conversion-report"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display
               value="MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"/>
    </targetReference>
  </relatesTo>
  <definition>
    <concept>
      <text value="End-stage kidney disease"/>
    </concept>
  </definition>
  <handling>
    <coding>
      <system value="https://fevir.net/sevco"/>
      <code value="STATO:0000090"/>
      <display value="dichotomous variable"/>
    </coding>
  </handling>
</EvidenceVariable>